GP6 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9HCN6 |
---|---|
Other Accession | NP_057447.4 |
Clone Names | 90504063 |
Gene ID | 51206 |
---|---|
Other Names | Platelet glycoprotein VI, GPVI, Glycoprotein 6, GP6 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | GP6 (HGNC:14388) |
---|---|
Function | Collagen receptor involved in collagen-induced platelet adhesion and activation. Plays a key role in platelet procoagulant activity and subsequent thrombin and fibrin formation. This procoagulant function may contribute to arterial and venous thrombus formation. The signaling pathway involves the FcR gamma-chain, the Src kinases (likely FYN or LYN) and SYK, the adapter protein LAT and leads to the activation of PLCG2. |
Cellular Location | [Isoform 1]: Cell membrane; Single-pass membrane protein |
Tissue Location | Megakaryocytes and platelets. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Glycoprotein VI (GP6) is a 58-kD platelet membraneglycoprotein that plays a crucial role in the collagen-inducedactivation and aggregation of platelets. Upon injury to the vesselwall and subsequent damage to the endothelial lining, exposure ofthe subendothelial matrix to blood flow results in deposition ofplatelets. Collagen fibers are the most thrombogenic macromolecularcomponents of the extracellular matrix, with collagen types I, III,and VI being the major forms found in blood vessels. Plateletinteraction with collagen occurs as a 2-step procedure: (1) theinitial adhesion to collagen is followed by (2) an activation stepleading to platelet secretion, recruitment of additional platelets,and aggregation. In physiologic conditions, the resulting plateletplug is the initial hemostatic event limiting blood loss. However,exposure of collagen after rupture of atherosclerotic plaques is amajor stimulus of thrombus formation associated with myocardialinfarction or stroke (Jandrot-Perrus et al., 2000 [PubMed10961879]).
References
Polgar, J., et al. J. Biol. Chem. 272(21):13576-13583(1997)Asselin, J., et al. Blood 89(4):1235-1242(1997)Huang, M.M., et al. Proc. Natl. Acad. Sci. U.S.A. 88(17):7844-7848(1991)Moroi, M., et al. J. Clin. Invest. 84(5):1440-1445(1989)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.